Ifeanyi Elibe Mba

University of Ibadan

Publishing since 2019, latest 2026

Infectious Diseases
Molecular Medicine
Molecular Biology
Applied Microbiology and Biotechnology
Food Science
Biomedical Engineering

Publications: 212019–2026
Citations: 1,085to those papers
h-index: 10i10-index 10
Field-weighted impact: 4.831.00 is the world average
World top 10%: 38%8 of 21 scored papers
Open access: 67%14 papers free to read

4 other works — preprints, datasets and the like — are listed but not counted.

By year

Papers, and the citations to them

Publications, left axisCitations to that year’s papers, right axis2026 still in progress

Citations received each year

Peerford

To all their work, old papers included. Google Scholar also counts citations from theses, books and web pages, so its line runs higher.

What they work on

From the classification of each paper

Career

On their papers

Every institution they have given on a paper.

Publications

21 in all

Mobilome-driven antimicrobial resistance in a one health context: evidence and lessons from Africa
2026Frontiers in Veterinary ScienceJournalOpen accessSenior author0 citations10.3389/fvets.2026.1805112
New insights and perspectives on the virulence of hypervirulent Klebsiella pneumoniae
2025Folia Microbiologica

Download CV:PDFWord

Subfields

Infectious Diseases838%
Molecular Medicine733%
Molecular Biology524%
Applied Microbiology and Biotechnology419%
Food Science419%
Biomedical Engineering314%
Materials Chemistry314%
Microbiology314%
Plant Science314%
Pollution314%

Health Sciences
Life Sciences
Physical Sciences

Topics most written on

Antibiotic Resistance in Bacteria7
Antifungal resistance and susceptibility6
Antibiotic Use and Resistance4
Probiotics and Fermented Foods4
Pharmaceutical and Antibiotic Environmental Impacts3
Advanced Nanomaterials in Catalysis2
Antimicrobial Peptides and Activities2
Bacterial biofilms and quorum sensing2
Bacteriophages and microbial interactions2
Fungal Infections and Studies2
Mycotoxins in Agriculture and Food2
Nanoparticles: synthesis and applications2

Who they write with

Their most frequent co-authors, and the papers those co-authors share

Where their co-authors are

24% of their papers have a co-author abroad

papers co-written2222333Home

Most frequent partner countries

United Kingdom3
United States2
Ukraine2

Papers with at least one author in that country.

Institutions written with most

University of NigeriaNG19 papers
Federal University of Health Sciences, OtukpoNG3 papers
Lead City UniversityNG3 papers
Sumy State UniversityUA2 papers
Western Kentucky UniversityUS2 papers
Federal Ministry of HealthNG2 papers
Enugu State University of Science and TechnologyNG2 papers
University of IlorinNG2 papers
Obafemi Awolowo UniversityNG2 papers
Osun State UniversityNG2 papers

Where they publish

World Journal of Microbiology and Biotechnology3
Bio Research Journal/Bio- Research2
Access Microbiology1
Antonie van Leeuwenhoek1
Biosafety and Health1
Brazilian Journal of Microbiology1
European Journal of Clinical Microbiology & Infectious Diseases1
Folia Microbiologica1

How it can be read

67% free to read

Diamond 2 · 10%Free to read and to publish
Gold 6 · 29%In an open-access journal
Bronze 4 · 19%Free to read, no open licence
Green 2 · 10%A copy in a repository
Closed 7 · 33%Behind a paywall

Development goals addressed

From each paper’s title and abstract

3Good health and well-being8
2Zero hunger3
15Life on land2
1No poverty1
10Reduced inequalities1

Most cited

Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects
World Journal of Microbiology and Biotechnology3
2021325 citationsWorld top 10%Open access · Bronze
Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms
Brazilian Journal of Microbiology
2022216 citationsWorld top 10%Open access · Bronze
Mechanism of Candida pathogenesis: revisiting the vital drivers
European Journal of Clinical Microbiology & Infectious Diseases2
2020145 citationsWorld top 10%
Antimicrobial Peptides Therapy: An Emerging Alternative for Treating Drug-Resistant Bacteria.
PubMed3
2022111 citationsWorld top 10%Open access · Green
The resurgence of phage-based therapy in the era of increasing antibiotic resistance: From research progress to challenges and prospects
Microbiological Research3
202277 citationsWorld top 10%Open access · Bronze

Combating antimicrobial resistance in Africa: a strategic roadmap for surveillance, stewardship, and research

2025Frontiers in Cellular and Infection MicrobiologyJournalOpen accessFirst authorCorresponding3 citations10.3389/fcimb.2025.1714021

Leveraging innovative diagnostics as a tool to contain superbugs

2025Antonie van LeeuwenhoekJournalSenior authorCorresponding2 citations10.1007/s10482-025-02075-y

Revisiting the smart metallic nanomaterials: advances in nanotechnology-based antimicrobials

2024World Journal of Microbiology and BiotechnologyJournalCorresponding6 citations10.1007/s11274-024-03925-z

Vaccine development for bacterial pathogens: Advances, challenges and prospects

2023Tropical Medicine & International HealthJournalOpen accessFirst authorCorresponding48 citations10.1111/tmi.13865

Antimicrobial resistance containment in Africa: Moving beyond surveillance

2023Biosafety and HealthJournalOpen accessCorresponding12 citations10.1016/j.bsheal.2023.12.003

Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms

2022Brazilian Journal of MicrobiologyJournalOpen accessSenior authorCorresponding216 citations10.1007/s42770-021-00675-0

Antimicrobial resistance: revisiting the mechanisms of resistance

2022Access MicrobiologyJournalOpen accessFirst author8 citations10.1099/acmi.ac2021.po0053

Immunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): a current update

2021Scandinavian Journal of Infectious DiseasesJournalOpen accessFirst authorCorresponding13 citations10.1080/23744235.2021.1916071

Mechanism of Candida pathogenesis: revisiting the vital drivers

2020European Journal of Clinical Microbiology & Infectious DiseasesJournalFirst author145 citations10.1007/s10096-020-03912-w

Who funds it

1 of 21 papers name a funder

Bill and Melinda Gates Foundation1
National Institute for Health and Care Research1